ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Lencioni Riccardo, Chen James
Despite the evolution of treatment for metastatic colorectal cancer (MCRC) over the past decade, improvements in survival endpoints have appeared to reach a plateau. The addition of expensive targeted biologic agents to the therapeutic armamentarium against M…
Avwioro Godwin, Iyiola Sina, Bankole Julius, Osiagwu Daniel, Muhammad Ahmad
This study examined cells contained in needles used for the collection of breast fine needle aspirates for the detection of malignant cells trapped in the needles. Remnants of cells contained in 50 needles used for the collection of scanty breast fine needle…
Lanowska Malgorzata, Brink-Spalink Verena, Hasenbein Kati, Schneider Achim, Marnitz Simone, Köhler Christhardt
Each year endometrial cancer is diagnosed in approximately 11.700 women in Germany. Operation is the therapy of choice in the primary treatment of patients with endometrial cancer. The traditional abdominal approach, vaginal, laparoscopic and robotic-assisted…
Englehardt Richard, Durrani Noreen, Mittal Vijay
Primary tumors of the appendix are rare, comprising 1.1% of all appendectomy specimens. Nevertheless, it often presents in an emergent fashion, creating a need for a well-defined management algorithm that will ensure proper acute management. We performed a re…
Di Jiabo, Yigit Refika, G. Figdor Carl, Duiveman-de Boer Tjitske, Massuger Leon, Torensma Ruurd
Cancer stem cells (CSCs) or tumor initiating cells are rare cells that are able to establish a tumor or metastasis. Identification of those CSCs is, however, cumbersome even in established cell lines. Several cancer stem cell markers were reported to be expre…
Hiroto Tanaka, Huuta Koga, Masako Hasegawa, Hiroshi Takihara, Eri Kimura, Tarou Inoue, Chie Ueda, Wataru Ono, Seigou Takamatsu, Yasushi Nakamura, Hiroki Ueda
A case of advanced multiple hepatocellular carcinomas (HCC) with portal vein tumor thrombosis successfully treated by oral tegafur/uracil is reported. A 69-year-old Japanese woman with advanced HCC with tumor thrombosis underwent transcatheter arterial infusi…
Patrick Wolf, Puneet Bhargava, Carlos Pellegrini, Peter C. Wu
Gallbladder cancer is the most common malignant tumor of the biliary tract and often diagnosed incidentally during laparoscopic cholecystectomy for gallbladder disease. This underscores the importance of considering the diagnosis of gallbladder cancer when co…
Rinat Eshel, Meirav Shpringer, Nadia Voskobinik, Akiva Vexler, Rami Ben-Yosef, Inna Fabian, Boris Tartakovsky, Elizabeth Naparstek
hile being instrumental in the treatment of leukemic relapse after allogeneic hematopoietic stem cell transplantation, the impact of donor lymphocyte infusion (DLI) and its effectiveness remain debatable. Consequently it is widely accepted that more efforts a…
Elmer Lodder, Maarten van der Elst
Complications after chest wall resection are common and are reported to occur in approximately 40% of patients. The most frequent complications are respiratory or wound complications. Restoring rib continuity after a resection is likely to prevent respiratory…
Ali Mohammad, Fauzia B. Faruqi, Jamal Mustafa
This paper represents the synthesis, spectral analysis and in-vitro cytotoxic studies of some novel fatty acid anti-cancer conjugates of 2, 6-diisopropylphenol (propofol). Propofol is a potent intravenous hypnotic agent which is widely used for the induction…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).